Direct Oral Anticoagulants and their Clinical Management
ثبت نشده
چکیده
Submit Manuscript | http://medcraveonline.com Abbreviations: DOACs: Direct Oral Anticoagulants; DVT: Deep Venous Thrombosis; PE: Pulmonary Embolus; PBS: Pharmaceutical Benefits Scheme; PD: Pharmacodynamic; PK: Pharmacokinetics; TGA: Therapeutic Good Administration; PCC: Prothrombin Complex Concentrate; PT: Prothrombin Time; aPTT: Activated Atrial Thromboplastin Time; FDA: Food and Drug Administration
منابع مشابه
Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
Direct oral anticoagulants targeting specific coagulation factors have been introduced as alternatives to conventional anticoagulants for both prophylactic and therapeutic indications. They have succeeded in overcoming the limitations of vitamin K antagonists. Although the favourable efficacy and side-effect profiles compared to vitamin K antagonists is proven, there is significant concern abou...
متن کاملOral Direct Anticoagulants in Thrombosis Management in Anti-Phospholipid Syndrome: Unanswered Questions
Anti-phospholipid syndrome comprises a broad spectrum of manifestations with thrombotic events as a serious issue. The current mainstay of treatment for thrombotic anti-phospholipid syndrome is heparin followed by long-term anticoagulation with vitamin K antagonists. Vitamin K antagonists’ management in this group of patients is frequently cumbersome, requires close monitoring and may affect pa...
متن کاملPerioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review
Direct oral anticoagulants (DOACs) are in wide use among patients requiring both short- and long-term anticoagulation, mainly due to their ease of use and the lack of monitoring requirements. With growing use of DOACs, it is imperative that physicians be able to manage patients on these medications, especially in the perioperative period. We aim to provide guidance on the management of DOACs in...
متن کاملANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives
It is now 4 years since the introduction of the new direct oral anticoagulants into clinical practice. Therefore, the Italian Association of Hospital Cardiologists (ANMCO) has deemed necessary to update the previous position paper on the prevention of thrombo-embolic complications in patients with non-valvular atrial fibrillation, which was published in 2013. All available scientific evidence h...
متن کاملComparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review
abstract:Acute Venous Thromboembolism (VTE) is a common disease associated with the significant morbidity and mortality. We reviewed clinical outcomes systematically with Dabigatran as a direct oral anticoagulants (DOAC) for treatment of acute VTE. We used Ovide, PubMed, Cochrane (CENTRAL), EMBASE, Scopus, Science Direct, LILAC(for article written not English) and also Iranian database; Magiran...
متن کامل